P-13-I

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameP-13-I
Drug Alias NameP-13-I
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionTyrosine-protein kinase BTK modulatorsProteolysis
TargetsTyrosine-protein kinase BTK
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesTsinghua UniversityBeijing Cancer Hospital
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Cancer HospitalTsinghua University
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A